CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websiteamgen.com
CategoryBioTech
Phone+1 805-447-1000
Employees
Founded1985
Descriptionbiotechnology company

Offices

HQ
One Amgen Center Drive
Thousand Oaks, CA, 91320-1799
USA

People

Business Planning Analyst

Former People

Technology Consultant
Sr. Research Operations Program Manager
Show All Former People

Acquisitions

Total$2.12B
KAI Pharmaceuticals, 4/12 $315M
BioVex, 1/11 $1B
Avidia, 10/08 $380M
Ilypsa, 6/07 $420M

Investments

Service Providers

Legal

Tags

Amgen

Amgen Inc.. The Group’s principal activities are to discover, develop, manufacture and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology and inflammation. The Group’s key products include Aranesp(R) (darbepoetin alfa), EPOGEN(R) (Epoetin alfa), Neulasta(R) (pegfilgrastim), NEUPOGEN(R) (Filgrastim) and Enbrel(R) (etanercept) stimulate the production of red blood cells, for the treatment of anemia associated with chronic renal failure. Neulasta(R) and NEUPOGEN(R) selectively stimulate the production of neutrophils, one type of white blood cell, for treatment of infection in-patients undergoing myelosuppressive chemotherapy. ENBREL(R) blocks the biologic activity of tumor necrosis factor, which is used for treating patients with active rheumatoid arthritis

Recent Milestones

Videos

Screenshots

Amgen screenshot
Above: Amgen Screenshot -- #1
Uploaded: 9/16/09

Sources

  1. UPDATED: Amgen snags KAI Pharma's CKD program in $315M buyout (fiercebiotech.com) [edit]
  2. BioVex to be acquired by Amgen for up to $1 billion (masshightech.com) [edit]
  3. Amgen to buy inflammation drug co. Avidia for up to $380M (deals.venturebeat.com) [edit]
  4. Amgen buys kidney-disease biotech Ilypsa for $420M (venturebeat.com) [edit]
  5. Gamida Cell Closes $10m Series E Financing (finsmes.com) [edit]
  6. Amgen pays Nektar $50M for polymer (fiercebiotech.com) [edit]
    BioVex to be acquired by Amgen for up to $1 billion (masshightech.com) [edit]
Edit This Page
Last Edited 5/5/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

Recent Incoming Links

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy